• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病中的内皮功能障碍:最新综述

Endothelial Dysfunction in Psoriasis: An Updated Review.

作者信息

Anyfanti Panagiota, Margouta Anastasia, Goulas Kyriakos, Gavriilaki Maria, Lazaridou Elizabeth, Patsatsi Aikaterini, Gkaliagkousi Eugenia

机构信息

Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Postgraduate Course, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

出版信息

Front Med (Lausanne). 2022 Jun 10;9:864185. doi: 10.3389/fmed.2022.864185. eCollection 2022.

DOI:10.3389/fmed.2022.864185
PMID:35755028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9226899/
Abstract

Although psoriasis is predominantly a chronic inflammatory skin disorder, epidemiological data provide a solid link between psoriasis, especially in its more severe forms, and increased risk for cardiovascular morbidity and mortality. Apart from the increased prevalence of traditional cardiovascular risk factors, chronic inflammation appears to act synergistically with the underlying process of endothelial dysfunction toward the development of accelerated atherosclerosis, subclinical vascular injury and subsequently, clinically evident cardiovascular manifestations. Endothelial dysfunction is regarded as an early precursor of atherosclerosis with a predictive value for the development of future cardiovascular events. A thorough understanding of the mechanisms of endothelial dysfunction in psoriasis might pave the path for the development of more accurate cardiovascular risk prediction tools and possible therapeutic targets aiming to alleviate the increased cardiovascular burden associated with the disease. The present review summarizes the available evidence about the role of chronic inflammation and other important pathophysiological mechanisms involved in the development of endothelial dysfunction in psoriasis. An overview of studies implementing the most widely applied circulating and vascular biomarkers of endothelial dysfunction in psoriasis patients will be provided, and the impact of systemic psoriasis treatments on endothelial dysfunction and patients' cardiovascular risk will be discussed.

摘要

尽管银屑病主要是一种慢性炎症性皮肤病,但流行病学数据表明,银屑病尤其是其更严重的形式与心血管疾病发病率和死亡率增加之间存在确凿联系。除了传统心血管危险因素的患病率增加外,慢性炎症似乎与内皮功能障碍的潜在过程协同作用,导致动脉粥样硬化加速发展、亚临床血管损伤,进而出现临床上明显的心血管表现。内皮功能障碍被认为是动脉粥样硬化的早期先兆,对未来心血管事件的发生具有预测价值。深入了解银屑病中内皮功能障碍的机制可能为开发更准确的心血管风险预测工具以及旨在减轻与该疾病相关的心血管负担增加的潜在治疗靶点铺平道路。本综述总结了关于慢性炎症和其他参与银屑病内皮功能障碍发展的重要病理生理机制作用的现有证据。将概述在银屑病患者中应用最广泛的循环和血管内皮功能障碍生物标志物的研究,并讨论全身性银屑病治疗对内皮功能障碍和患者心血管风险的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f99/9226899/710ac24142f4/fmed-09-864185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f99/9226899/710ac24142f4/fmed-09-864185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f99/9226899/710ac24142f4/fmed-09-864185-g001.jpg

相似文献

1
Endothelial Dysfunction in Psoriasis: An Updated Review.银屑病中的内皮功能障碍:最新综述
Front Med (Lausanne). 2022 Jun 10;9:864185. doi: 10.3389/fmed.2022.864185. eCollection 2022.
2
Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis.银屑病患者的全身炎症以及内皮损伤与修复之间的失衡与临床前动脉粥样硬化相关。
Eur J Prev Cardiol. 2015 Aug;22(8):1027-35. doi: 10.1177/2047487314538858. Epub 2014 Jun 6.
3
Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease.血小板活化:银屑病及其合并症、心血管疾病的促进因素。
Front Immunol. 2023 Aug 15;14:1238647. doi: 10.3389/fimmu.2023.1238647. eCollection 2023.
4
Psoriasis as a cardiovascular risk factor: updates and algorithmic approach.银屑病作为心血管危险因素:最新进展及算法方法
G Ital Dermatol Venereol. 2018 Oct;153(5):659-665. doi: 10.23736/S0392-0488.18.06040-6. Epub 2018 Apr 19.
5
Potential Immunological Links Between Psoriasis and Cardiovascular Disease.银屑病与心血管疾病之间潜在的免疫学联系。
Front Immunol. 2018 Jun 1;9:1234. doi: 10.3389/fimmu.2018.01234. eCollection 2018.
6
The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.白细胞介素-17/白细胞介素-23抑制剂治疗对斑块状银屑病和/或银屑病关节炎患者亚临床动脉粥样硬化的影响:一项系统评价
Biomedicines. 2023 Jan 23;11(2):318. doi: 10.3390/biomedicines11020318.
7
Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.银屑病和银屑病关节炎的心脏代谢合并症。
Int J Mol Sci. 2017 Dec 25;19(1):58. doi: 10.3390/ijms19010058.
8
Subclinical cardiovascular disease in plaque psoriasis: association or causal link?斑块型银屑病的亚临床心血管疾病:关联还是因果关系?
Atherosclerosis. 2014 Jan;232(1):72-8. doi: 10.1016/j.atherosclerosis.2013.10.023. Epub 2013 Nov 1.
9
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.系统性炎症与银屑病患者心血管共病:病因与后果。
Front Immunol. 2018 Apr 5;9:579. doi: 10.3389/fimmu.2018.00579. eCollection 2018.
10
Endothelial dysfunction in chronic inflammatory diseases.慢性炎症性疾病中的内皮功能障碍。
Int J Mol Sci. 2014 Jun 25;15(7):11324-49. doi: 10.3390/ijms150711324.

引用本文的文献

1
Cardiometabolic Comorbidities of Lichen Planus-A Cross-Sectional Comparative Study.扁平苔藓的心脏代谢合并症——一项横断面比较研究
Diagnostics (Basel). 2025 Aug 14;15(16):2039. doi: 10.3390/diagnostics15162039.
2
Psoriasis Beyond the Skin: A Disease With Cardiovascular Risk.银屑病不止于皮肤:一种具有心血管风险的疾病。
Cureus. 2025 Jul 21;17(7):e88464. doi: 10.7759/cureus.88464. eCollection 2025 Jul.
3
Association Between Systemic Inflammation, Metabolic Syndrome and Quality of Life in Psoriasis Patients.银屑病患者全身炎症、代谢综合征与生活质量之间的关联

本文引用的文献

1
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial.对于体重 90 公斤或以上的银屑病患者,每 2 周接受司库奇尤单抗治疗的疗效优于每 4 周接受司库奇尤单抗治疗:一项随机对照试验的结果。
Br J Dermatol. 2022 Jun;186(6):942-954. doi: 10.1111/bjd.20971. Epub 2022 Apr 8.
2
Plasma atherogenic indices are independent predictors of slow coronary flow.血浆致动脉粥样硬化指数是冠状动脉慢血流的独立预测因子。
BMC Cardiovasc Disord. 2021 Dec 20;21(1):608. doi: 10.1186/s12872-021-02432-5.
3
Endothelial glycocalyx and microvascular perfusion are associated with carotid intima-media thickness and impaired myocardial deformation in psoriatic disease.
Life (Basel). 2025 Jan 31;15(2):212. doi: 10.3390/life15020212.
4
S1PR1-biased activation drives the resolution of endothelial dysfunction-associated inflammatory diseases by maintaining endothelial integrity.S1PR1偏向性激活通过维持内皮完整性驱动与内皮功能障碍相关的炎症性疾病的消退。
Nat Commun. 2025 Feb 20;16(1):1826. doi: 10.1038/s41467-025-57124-x.
5
Arterial function is preserved in successfully treated patients with psoriasis vulgaris.动脉功能在寻常型银屑病治疗成功的患者中得以保留。
Sci Prog. 2024 Oct-Dec;107(4):368504241287893. doi: 10.1177/00368504241287893.
6
Stromal cells and epigenetics: emerging key players of chronic inflammatory skin diseases.基质细胞与表观遗传学:慢性炎症性皮肤病中新兴的关键因素。
BMB Rep. 2024 Nov;57(11):465-471. doi: 10.5483/BMBRep.2024-0039.
7
Epicardial Adipose Tissue and Psoriasis: A Systematic Review and Meta-Analysis.心外膜脂肪组织与银屑病:一项系统评价和荟萃分析
J Clin Med. 2024 Aug 13;13(16):4761. doi: 10.3390/jcm13164761.
8
Calcipotriol/Betamethasone Dipropionate for the Treatment of Psoriasis: Mechanism of Action and Evidence of Efficacy and Safety versus Topical Corticosteroids.卡泊三醇/倍他米松二丙酸酯治疗银屑病:作用机制及与外用皮质类固醇相比的疗效和安全性证据
J Clin Med. 2024 Jul 31;13(15):4484. doi: 10.3390/jcm13154484.
9
Novel biomarkers and psoriasis associated cardiovascular risk.新型生物标志物与银屑病相关的心血管风险。
Arch Dermatol Res. 2024 May 2;316(5):140. doi: 10.1007/s00403-024-02891-8.
10
HPLC- and NMR-Based Chemical Profiling, Wound-Healing Potential, Anti-Inflammatory and Antibacterial Activities of (Lamiaceae), a Neglected Medicinal-Aromatic Herb.基于高效液相色谱和核磁共振的化学剖析、一种被忽视的药用芳香草本植物(唇形科)的伤口愈合潜力、抗炎和抗菌活性
Plants (Basel). 2023 Dec 8;12(24):4114. doi: 10.3390/plants12244114.
内皮糖萼和微血管灌注与银屑病患者的颈动脉内膜中层厚度和心肌变形受损有关。
J Hum Hypertens. 2022 Dec;36(12):1113-1120. doi: 10.1038/s41371-021-00640-2. Epub 2021 Nov 25.
4
Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics.银屑病与心血管疾病:新机制与不断发展的治疗策略。
Curr Atheroscler Rep. 2021 Sep 1;23(11):67. doi: 10.1007/s11883-021-00963-y.
5
TNF-α blockade may lead to improvement of vascular function in psoriasis patients.肿瘤坏死因子-α阻断可能会改善银屑病患者的血管功能。
Exp Dermatol. 2022 Feb;31(2):237-241. doi: 10.1111/exd.14452. Epub 2021 Sep 1.
6
Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities.自身免疫性慢性炎症性疾病患者在无疾病发作和心血管合并症的情况下,血栓炎症和内皮功能障碍的生物标志物水平会升高。
J Thromb Thrombolysis. 2022 Jan;53(1):10-16. doi: 10.1007/s11239-021-02517-0. Epub 2021 Jul 5.
7
Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.生物制剂对银屑病患者心血管疾病影像学和生物标志物的影响:一项随机安慰剂对照试验的系统评价和荟萃分析。
J Invest Dermatol. 2021 Oct;141(10):2402-2411. doi: 10.1016/j.jid.2021.03.024. Epub 2021 Apr 21.
8
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial.比美吉珠单抗治疗中重度斑块型银屑病的疗效和安全性(BE READY):一项多中心、双盲、安慰剂对照、随机撤药阶段 3 期临床试验。
Lancet. 2021 Feb 6;397(10273):475-486. doi: 10.1016/S0140-6736(21)00126-4.
9
Platelet microvesicles are associated with the severity of coronary artery disease: comparison between peripheral and coronary circulation.血小板微囊与冠状动脉疾病的严重程度有关:外周循环与冠状动脉循环的比较。
J Thromb Thrombolysis. 2021 May;51(4):1138-1143. doi: 10.1007/s11239-020-02302-5. Epub 2020 Oct 11.
10
Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2).替西罗莫司治疗银屑病的疗效、药物存活率和安全性在合并和不合并代谢综合征的患者中相当:来自 2 项 3 期随机对照研究(reSURFACE 1 和 reSURFACE 2)的长期结果。
J Am Acad Dermatol. 2021 Feb;84(2):398-407. doi: 10.1016/j.jaad.2020.09.047. Epub 2020 Sep 19.